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1. Introduction 
The heart is the first organ to develop and its proper formation is requisite for survival of 
the embryo. Heart development relies on exquisitely controlled signaling cascades that 
together weave the temporal and spatial cardiac gene expression patterns required for 
normal heart morphogenesis and function. Aberrations in cardiogenic signaling pathways 
or in cardiac gene expression patterns can result in congenital heart defects (CHDs), the 
most common type of birth defect worldwide and the leading noninfectious cause of infant 
death in the Western world (Hoffman 1995; Hoffman and Kaplan 2002). This review 
provides evidence from multiple experimental models that demonstrates the conserved, 
critical roles of Bone Morphogenetic Protein (BMP) signaling pathways throughout heart 
development, from induction of the cardiac mesoderm to the formation of the four-
chambered heart. BMP signaling pathways have roles in developmental processes that can 
contribute to CHDs, including formation of the septa, valves, and outflow tract.  
2. Overview 
2.1 Heart development 
During gastrulation, cardiac progenitors within the lateral plate mesoderm migrate in 
bilateral sheets of cells to the anterior of the embryo. Within the cardiac mesoderm, there are 
two populations of cells that contribute to the developing heart called the first and second 
heart fields (FHF and SHF, respectively).  At embryonic (E) day 7.5 in mice, cells of the FHF 
form the cardiac crescent. At this stage, the second population of cardiac cells, the SHF, is 
medial and anterior to the FHF. As the embryo folds, at mouse E8.0, the cardiac crescent 
fuses along the midline and forms the heart tube while the SHF moves dorsally. The heart 
tube consists of an outer myocardial layer and an inner endocardial layer, separated by an 
extracellular matrix (ECM) called the cardiac jelly. SHF cells migrate through the pharyngeal 
mesoderm to populate the anterior and posterior regions of the heart tube. Starting from 
E8.5 in the mouse, the heart undergoes rightward looping. Regional proliferation along the 
myocardium of the outer curvature of the heart tube demarcates the future atrial and 
ventricular chambers. The myocardium of the inflow tract (IFT), outflow tract (OFT), 
atrioventricular canal (AVC) and inner curvature of the heart tube is characteristically non-
proliferative. The FHF contributes primarily to the left ventricle as well as to part of the 
atrium, and the SHF contributes to the atria, right ventricle, and OFT. At about E9.5 in the 
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AVC, the endocardial cells respond to signals from the myocardium and undergo epithelial 
to mesenchymal transition (EMT) to form the cushions, the primordial valve structures. 
Cushions are also formed in the proximal region of the OFT at a slightly later stage. Around 
E10.0, another population of cells called the cardiac neural crest cells (CNCC) migrates from 
the dorsal neural tube and contributes to the developing OFT. By E11.5, the proepicardial 
cells have migrated around and enveloped the heart, forming the epicardium. Finally, 
septation and valve development result in a four-chambered heart with right, pulmonary, 
and left, systemic, halves by mouse E14.5. For a review, see (Evans et al. 2010).  
2.2 BMP signaling pathways 
BMP ligands are conserved growth factors that belong in the Transforming Growth Factor-┚ 
(TGF┚) superfamily. More than twenty BMPs have been identified and they have a myriad 
of functions during development. BMP precursor proteins are activated via endoproteolytic 
cleavage, glycosylated, and then secreted as homo- or hetero-dimers (Derynck et al. 1985; 
Derynck et al. 1986; Wozney et al. 1990). Once processed and secreted, BMP ligands relay 
their signal to the nucleus through signaling cascades that utilize unique combinations of 
serine threonine kinase receptors which respond to specific ligand combinations. There are 
three type I receptors (out of seven) and three type II receptors (out of five) that transduce 
the BMP signals. The type I receptors are ALK2 (ACVRI, ACTRI), ALK3 (BMPRIA/BRK-1), 
and ALK6 (BMPRIB, BRK-2) (Macías-Silva et al. 1998; Koenig et al. 1994; ten Dijke et al. 
1994). The type II receptors are BMPR2 (BMPRII, BRK-3), ACVR2A (ACTRIIA), and 
ACVR2B (ACTRIIB) (Yamashita et al. 1995; Nohno et al. 1995; Rosenzweig et al. 1995; 
Kawabata, Chytil, and Moses 1995). The BMP dimer binds a type II receptor, which recruits 
and phosphorylates a type I receptor in its intracellular kinase domain (Yamashita et al. 
1995). The type I receptor then phosphorylates an intracellular receptor-regulated SMAD 
protein (R-SMAD). SMAD1, SMAD5, and SMAD8 are activated specifically by BMP signals 
(Cárcamo, Zentella, and Massagué 1995; Wieser, Wrana, and Massagué 1995; Hoodless et al. 
1996; Nishimura et al. 1998; Chen, Bhushan, and Vale 1997). After phosphorylation, 
activated R-SMADs form a complex with the common SMAD, SMAD4 (Zhang, Musci, and 
Derynck 1997). The R-SMAD-SMAD4 complex translocates to the nucleus, where it 
cooperates with other cofactors to regulate gene transcription; an example is illustrated 
elsewhere (Jiao, Zhou, and Hogan 2002). BMP signaling can occur independently of SMAD 
proteins in non-canonical pathways. For example, BMPs can activate MAP kinase pathways, 
resulting in the activation of p38 MAPK, PI3K, ERK, and JNK with downstream effects on 
cell proliferation and differentiation (Yamaguchi et al. 1995; Shibuya et al. 1998; Kimura et 
al. 2000; Lou et al. 2000; Lai and Cheng 2002; Yanagisawa et al. 2001; Xu et al. 1996).  
It has recently been demonstrated that BMP signaling can regulate microRNA (miRNA) 
biosynthesis. miRNAs are short non-coding RNA that target messenger RNA (mRNA) in a 
sequence-specific manner for post-transcriptional degradation and translational inhibition. 
miRNAs are transcribed as primary miRNAs (pri-miRNAs), which are processed by the 
Drosha complex within the nucleus. pri-miRNA processing results in a shorter pre-miRNA, 
which is exported from the nucleus to the cytoplasm where it is cleaved into its mature 
miRNA structure by Dicer. For a review on miRNA during cardiovascular development and 
disease, the reader is referred to Liu and Olson (2010). Activated R-SMADs can directly 
interact with the microprocessor complex, Drosha, independent of the common SMAD, 
SMAD4, to promote the biosynthesis of miRNAs such as miR-21 (Davis et al. 2008; Ji et al. 
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2007; Warner et al. 2004; Fukuda et al. 2007; Davis et al. 2010). miR-21 is upregulated in 
damaged cardiovascular tissue (Ji et al. 2007).  
The timing, duration, and gradient of BMP ligands affect the outcomes and add to the 
complexity of BMP signaling pathways. After BMP processing and secretion, access to the 
receptors and retention in the ECM are inhibited by extracellular factors such as noggin, 
chordin, follistatin, cerberus, and gremlin (McMahon et al. 1998; Streit et al. 1998; Sasai et al. 
1995; Hemmati-Brivanlou, Kelly, and Melton 1994; Fainsod et al. 1997; Bouwmeester et al. 
1996; Hsu et al. 1998). These inhibitors bind BMP ligands, interfering with ligand-receptor 
interaction (Zimmerman, De Jesús-Escobar, and Harland 1996; Hsu et al. 1998; Yamashita et 
al. 1995; Piccolo et al. 1996; Iemura et al. 1998). BMP signaling is also regulated at the 
membrane, for instance by the pseudoreceptor BAMBI (BMP and Activin membrane bound 
inhibitor). BAMBI lacks the intracellular domain needed to transduce the signal and, upon 
binding BMP receptors, it inhibits the formation of an active BMP receptor complex 
(Onichtchouk et al. 1999; Grotewold et al. 2001). Alternatively, BMP signaling can be 
enhanced at the membrane level by modulators such as DRAGON, which acts as a co-
receptor and presents BMPs to the receptors (Samad et al. 2005; Babitt et al. 2005; Babitt et al. 
2006). Another example is endoglin, a transmembrane protein that binds to BMP ligands 
and enhances BMP signaling (Barbara, Wrana, and Letarte 1999; Scherner et al. 2007). 
Intracellularly, BMP signaling can be downregulated by SMURF, an E3 ubiquitin ligase that 
promotes R-SMAD degradation, receptor turnover, and facilitates inhibition by the 
inhibitory SMADs, SMAD6 and SMAD7 (Murakami et al. 2003; Kavsak et al. 2000; Ebisawa 
et al. 2001). SMAD6 and SMAD7 inhibit BMP signaling cascades through binding active 
type I BMP receptors and preventing R-SMAD activation, and by competing with SMAD4 
for R-SMADs (Imamura et al. 1997; Hata et al. 1998; Hanyu et al. 2001). Lastly, crosstalk with 
other signaling pathways affects R-SMAD phosphorylation, activity, turnover and nuclear 
accumulation (Pera et al. 2003; Sapkota et al. 2007; Fuentealba et al. 2007; Suzawa et al. 2002). 
3. BMP signaling in heart development 
3.1 Cardiac specification and heart tube formation 
In this section, we will review the functions of different components of BMP signaling 
during the initial stages of heart development. 
3.1.1 BMP ligands 
Initial insight into the roles of BMP signaling pathways in cardiac specification came from 
studying the BMP2/4 ortholog, Dpp, in Drosophila melanogaster. Dpp-deficient larva did not 
form the precursor cells for the heart organ, the dorsal vessel, while ectopic DPP caused 
ectopic formation of the dorsal vessel precursor cells (Xu et al. 1998; Frasch 1995; Yin and 
Frasch 1998). In the anterior region of chick embryos, the endoderm expresses BMP2 and 5, 
and the ectoderm expresses BMP4 and BMP7 (Schultheiss, Burch, and Lassar 1997; Somi et 
al. 2004). In vivo and in vitro experiments using chicken embryos revealed that both the FHF 
and the SHF pre-cardiac mesodermal cells differentiate in response to BMP signals (Waldo 
et al. 2001; Tirosh-Finkel et al. 2006). In mice, BMP2, BMP4, BMP5, and BMP7 are expressed 
in the anterior mesoderm (Zhang and Bradley 1996; Dudley and Robertson 1997; Solloway 
and Robertson 1999). Regardless of the differences in BMP expression patterns between 
species, it has been well-established that BMP signaling pathways induce precardiac 
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mesoderm to undergo cardiac differentiation (Alsan and Schultheiss 2002; Barron, Gao, and 
Lough 2000; Tirosh-Finkel et al. 2010). Bmp2 deletion in mice causes embryonic lethality 
between E7.5-E9.0 (Zhang and Bradley 1996). Some mutant embryos lack hearts altogether 
and others develop ectopic heart tubes in the exocoelomic cavity, suggesting a critical role of 
BMP signaling for heart formation (Zhang and Bradley 1996).  
BMP signaling pathways induce cardiac differentiation through upregulation of cardiogenic 
genes. Expression of the cardiac transcription factors Nkx2.5 and Gata4 is initiated by BMP 
signaling (Frasch 1995; Schultheiss, Burch, and Lassar 1997; Andrée et al. 1998; Schlange et 
al. 2000; Jamali et al. 2001; Liberatore et al. 2002; Shi et al. 2000; Lien et al. 2002; Reiter, 
Verkade, and Stainier 2001; Schultheiss, Xydas, and Lassar 1995). The Nkx2.5 promoter 
region contains evolutionary conserved BMP-response elements that are necessary for its 
cardiac expression (Lien et al. 2002; Liberatore et al. 2002; Brown et al. 2004). BMP signaling 
also activates the expression of myocardin, a cardiac and smooth muscle-specific 
transcriptional cofactor for serum response factor, a regulator of cardiac differentiation 
(Arsenian et al. 1998; Wang et al. 2001; Callis, Cao, and Wang 2005). SMAD1 is also a 
transcriptional cofactor for myocardin to activate downstream gene expression (Callis, Cao, 
and Wang 2005).  
3.1.2 BMP receptors  
The BMP type I receptor ALK3 is widely expressed in mouse embryos and Alk3 deletion 
causes embryonic lethality at E8.0 with no mesoderm formation (Mishina et al. 1995; Dewulf 
et al. 1995). ALK2, another type I receptor, is expressed in Hensen’s node and in the 
primitive streak (Gu et al. 1999; Mishina et al. 1999). Deleting Alk2 in mouse embryos results 
in gastrulation defects and embryonic lethality before E9.5 (Gu et al. 1999; Mishina et al. 
1999). The third type I receptor, ALK6, is not expressed during early heart development and 
disrupting its function does not affect mouse cardiogenesis or viability (Dewulf et al. 1995; 
Yi et al. 2000). Knockout of the type II receptor, BMPR2, which is expressed widely 
throughout chicken embryos and during mouse cardiomyogenesis, causes embryonic 
lethality at gastrulation (Ehrman and Yutzey 1999; Stern et al. 1995; Feijen, Goumans, and 
van den Eijnden-van Raaij 1994; Beppu et al. 2000). In mice, ACVR2A is expressed after 
cardiomyocyte formation at E9.5 and ACVR2B is ubiquitously expressed during 
cardiomyogenesis (Feijen, Goumans, and van den Eijnden-van Raaij 1994; Beppu et al. 2000). 
Disruption of Acvr2a alone does not cause heart defects and disruption of Acvr2b causes 
heart defects later in development (Matzuk, Kumar, et al. 1995; Oh and Li 1997).  However, 
deletion of both Acvr2a and Acvr2b results in embryonic death at gastrulation, suggesting 
functional redundancy of these type II receptors (Song et al. 1999). 
3.1.3 SMAD proteins 
In chicken embryos, the receptor-regulated SMAD proteins, SMAD1, SMAD5, and SMAD8, 
are enriched in the heart forming region (Faure et al. 2002). In mice, Smad1 and Smad5 
mRNA are expressed in the mesoderm during cardiomyocyte formation (Tremblay, Dunn, 
and Robertson 2001). Smad1 disruption in mice results in embryonic lethality at E10.5 from 
failure of umbilical-placental connections to form (Tremblay, Dunn, and Robertson 2001). 
Germline deletion of Smad5 results in defective left-right symmetry with a heart looping 
abnormality and defective angiogenesis (Chang et al. 2000; Yang et al. 1999). Deletion of 
Smad4, the gene encoding the common SMAD, causes death before E7.5, with reduced size 
www.intechopen.com
 
Bone Morphogenetic Protein Signaling Pathways in Heart Development and Disease 
 
101 
and failure to gastrulate (Sirard et al. 1998). Conditional deletion of Smad4 from the epiblast 
causes embryonic lethality by E8.5, but the heart tube forms and Nkx2.5 is expressed (Chu et 
al. 2004). Heart tube formation and cardiac gene expression may occur in these mice because 
canonical BMP signaling occurs before Smad4 deletion or because other R-SMAD 
transcriptional cofactors compensate for the loss of SMAD4. 
3.1.4 BMP inhibitors 
Inhibition of BMP during gastrulation restricts the heart forming fields to discrete territories 
in the anterior of the embryo. Noggin, chordin, and follistatin are secreted from the 
notochord and bind BMP ligands, preventing receptor activation (McMahon et al. 1998; 
Streit et al. 1998; Sasai et al. 1995; Hemmati-Brivanlou, Kelly, and Melton 1994; Fainsod et al. 
1997). The responsiveness of pre-cardiac mesoderm to inhibitory signals from the notochord 
is developmentally regulated. Ectopic application of noggin to stage 4 chick mesendoderm 
prevents the initiation of the cardiac gene expression and development of the contracting 
cardiomyocytes (Schultheiss, Burch, and Lassar 1997; Schlange et al. 2000). If noggin is 
applied to explants a stage later, the cardiac gene expression is initiated without 
spontaneous contraction of myocytes. If noggin is applied at stage 6, differentiation occurs 
normally (Nakajima et al. 2002). In mice, deletion of noggin or follistatin individually does 
not cause heart defects, but deletion of both reverses heart looping (Bachiller et al. 2000; 
McMahon et al. 1998; Matzuk, Lu, et al. 1995). Deleting chordin causes defects 
phenocopying those in DiGeorge syndrome (Bachiller et al. 2003). 
3.2 Cardiogenesis after heart tube formation 
In this section, we will discuss BMP signaling during different cardiogenic processes after 
heart tube formation. 
3.2.1 Myocardial wall morphogenesis 
During early heart development, myocardial walls expand through cardiomyocyte 
proliferation and differentiation. The ventricle chamber myocardium develops a latticework 
of muscular projections on the subendocardial surface called trabeculae. Trabecular 
myocardium generates contractile force, coordinates intraventricular conduction, and helps 
diffuse nutrients to the cardiomyocytes within the expanding heart wall prior to    
vascularization. Later in heart development, the trabecular myocardium undergoes 
remodeling and is incorporated into the compact myocardium, the interventricular septum, 
and the papillary muscles of the atrioventricular valves. For a review, see Dunwoodie 
(2007). Proper formation of myocardial walls is essential for embryo viability and postnatal 
cardiac function. Abnormal myocardial wall morphogenesis can result in left ventricular 
noncompaction, which may lead to cardiomyopathy (Pignatelli et al. 2003; Xing et al. 2006). 
BMP10 is initially expressed in the looping mouse heart within regions destined to be the 
atrial and ventricular chambers, and its expression is maintained in the chamber 
myocardium during heart development. (Neuhaus, Rosen, and Thies 1999; Somi et al. 2004; 
Chen et al. 2004) Also, Bmp10 is upregulated in mouse models of hypertrabeculation (Chen 
et al. 2004). Myocardial expression of BMP10 during chamber formation relies on 
endocardial expression of notch (Grego-Bessa et al. 2007). Deleting Bmp10 in mice causes 
embryonic lethality at E9.0 with decreased cardiomyocyte proliferation, downregulation of 
cardiac genes Nkx2.5 and Mef2c, and loss of trabecular myocardium (Chen et al. 2004). 
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Removing both Bmp6 and Bmp7 in mice causes embryonic lethality at midgestation with 
hypoplastic ventricles and reduced trabeculations (Kim, Robertson, and Solloway 2001). 
Mice with conditional deletion of the BMP receptor Alk3 from the myocardium die during 
embryogenesis and display underdeveloped myocardial walls and ventricle septal defects 
(VSD) (Gaussin et al. 2002). Specific inactivation of the common Smad, Smad4, from the 
myocardium likewise causes embryonic lethality at midgestation and disrupts myocardial 
wall formation and ventricle septation (Azhar et al. 2010; Song, Yan, et al. 2007; Qi et al. 
2007; Wang, Xu, et al. 2005). Myocardial deletion of Smad4 causes downregulation of genes 
encoding cell cycle regulators, cardiac structural proteins, and transcription factors. 
Together, these studies provide multiple lines of evidence that show BMP signaling is 
required for ventricular myocardial wall morphogenesis through regulation of 
cardiomyocyte proliferation, differentiation, and gene expression.  
3.2.2 Conduction system development 
In vertebrates, regional differentiation of the myocardium allows for development of slow-
conducting, nonchamber myocardium (IFT, AVC, and OFT) and fast-conducting chamber 
myocardium (atria and ventricles). Proper formation of the AVC is important for 
establishment of the primary conduction system. The primary conduction system includes 
the atrioventricular node (AVN) and its associated structures. In mice, AVN precursor cells 
are observed in the AVC at E9.5. The AVN subsequently extends into the left ventricle and 
connects with the trabecular myocardium and the interventricular septum. (See reviews, 
(Christoffels et al. 2010; Moorman and Christoffels 2003)). The electrical impulse is carried 
from the atria, across the AVC to the ventricles (Valderrábano et al. 2006; Rentschler et al. 
2002; de Jong et al. 1992). The AVC has a slower conduction rate than the atria and delays 
the atrial-ventricular electrical impulse (de Jong et al 1992).  
BMP2 is necessary for AVC specification and expression of Tbx2 (Yamada et al. 2000; Ma et 
al. 2005). TBX2 is a transcriptional repressor of chamber-specific genes and is specifically 
expressed in nonchamber myocardium of the IFT and the AVC (Aanhaanen et al. 2009; 
Habets et al. 2002; Yamada et al. 2000; Christoffels et al. 2004; Harrelson et al. 2004). In the 
AVC, BMP2 activates Tbx2 transcription to suppress proliferation and inhibit the expression 
of chamber-specific genes Nppa, Cx40, Cx43, and Chisel (Ma et al. 2005; Shirai et al. 2009; 
Christoffels et al. 2004). BMP2 can directly regulate Tbx2 through a SMAD-dependent 
enhancer upstream of its transcription start site (Singh et al. 2009). BMP signaling also 
promotes Tbx2 transcription through SMAD1 inhibition of TBX20, a Tbx2 repressor (Singh et 
al. 2009). The BMP2-TBX2 pathway is restricted to the AVC region by notch/HEY signaling 
in the developing heart chambers (Rutenberg et al. 2006; Kokubo et al. 2005).  
Deletion of Bmp2 from mouse myocardium decreases Tbx2 expression and results in the 
expansion of chamber myocardium into the AVC region (Ma et al. 2005). Inactivation of the 
BMP receptor Alk3 specifically in the AVC myocardium disrupts AV valve development 
and AVN morphogenesis, resulting in ventricular pre-excitation (Gaussin et al. 2005; Stroud 
et al. 2007).  Lastly, removal of myocardial Tbx2 results in abnormal AVC patterning and 
ventricular pre-excitation (Aanhaanen et al. 2011). Taken together, these data suggest that 
BMP2 regulation of Tbx2 expression and AVC myocardial patterning is important for 
development of the AVN and proper atrial-ventricular conduction. Indeed, the phenotype 
resulting from AVC-depletion of Alk3 resembles Wolff-Parkinson-White syndrome (WPWS, 
OMIM 224700), a pre-excitation syndrome that can present as tachycardia due to an 
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abnormal connection between the atria and ventricles (Gaussin et al. 2005). Recently, a 
heterozygous microdeletion was identified in a chromosomal region encompassing BMP2 
that is associated with predisposition to WPWS (Lalani et al. 2009).  
3.2.3 Valvulo-septal development of the atrioventricular canal and outflow tract 
The AVC and OFT are septated by endocardial cushion maturation into valvulo-septal 
structures. Cushions develop in the AVC and OFT through the expansion of the ECM. 
Induction of cushion formation occurs within the looped heart, when the myocardium 
signals through the cardiac jelly to the endocardium. Endocardial cells then delaminate and 
invade the cardiac jelly to form the mesenchymal cells of the endocardial cushions. For 
reviews, see Person, Klewer, and Runyan (2005) and Butcher and Markwald (2007). The 
AVC cushions form earlier than the OFT cushions and develop into the mitral (left) and 
tricuspid (right) valves at the junction of the atria and ventricles. The OFT cushions, but not 
the AVC cushions, have a CNCC contribution (Kirby, Gale, and Stewart 1983; Waldo et al. 
1998; Jiang et al. 2000). The cushions in the OFT develop into the semilunar valves in the 
aorta (left) and pulmonary artery (right). Congenital defects in valve formation and 
septation comprise the most common CHDs, while defects involving the OFT are found in 4 
per 10,000 live births and are often lethal (Hoffman 1995; Edmonds and James 1993). 
Pathological mutations in the BMP receptor ALK2 have been found in patients with 
congenital defects in atrioventricular septum development, providing evidence for the 
importance of BMP signaling pathways in human heart development (Smith et al. 2009; 
Joziasse et al. 2011). 
At E9.5 in mice, BMP2 has weak expression in OFT myocardium which disappears by E10.5 
(Lyons, Pelton, and Hogan 1990). BMP2 is strongly and persistently expressed in AVC and 
atrial myocardium at E10.5 (Lyons, Pelton, and Hogan 1990; Abdelwahid et al. 2001). It is 
also expressed in the cushion mesenchyme during valve remodeling and in adult mouse 
valves (Sugi et al. 2004). In mice, BMP2 enhances cardiac jelly formation, endocardial EMT, 
and AVC myocardial patterning (Ma et al. 2005; Rivera-Feliciano and Tabin 2006; Sugi et al. 
2004; Camenisch et al. 2002). BMP2 upregulates Twist1, an inducer of EMT, and Has2, a 
component of the cardiac jelly necessary for EMT (Camenisch et al. 2000; Ma et al. 2005; 
Yang et al. 2004). Myocardial deletion of Bmp2 decreases ECM in the AVC cushions, 
however the OFT cushions develop normally (Ma et al. 2005; Rivera-Feliciano and Tabin 
2006). This suggests a compensatory mechanism in the OFT such as BMP4 signaling. Data 
suggests that BMP2 signaling interacts with notch1 and TGF┚ signaling pathways to 
coordinate EMT (Luna-Zurita et al. 2010; Boyer et al. 1999; Yamagishi et al. 1999). 
BMP4 is expressed in AVC myocardium in mice at E9.5, but at E10.5 its expression is largely 
restricted to the myocardium of the OFT (Jones, Lyons, and Hogan 1991; Abdelwahid et al. 
2001). It is also expressed in the chicken OFT (Somi et al. 2004). BMP4 is 92% identical in the 
C-terminus to BMP2, and they have overlapping functions (Goldman, Donley, and Christian 
2009; Uchimura et al. 2009). Conditional deletion of Bmp4 from mouse myocardium causes 
atrioventricular septation defects, double outlet right ventricle (DORV, both arteries are 
connected to the right ventricle), and aortic arch artery malformations (Jiao et al. 2003; Liu et 
al. 2004). Mouse models with myocardial-specific deletion of Bmp4 or with hypomorphic 
Bmp4 alleles have impaired AVC cushion mesenchymal cell proliferation (Jiao et al. 2003; 
Kulessa and Hogan 2002). Mice compound heterozygous for Bmp2-null and Bmp4-null or 
Bmp4-hypomorphic alleles have VSD (Goldman, Donley, and Christian 2009). Decreased 
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expression of myocardial BMP4 does not affect OFT development, but it increases BMP7 
expression (Liu et al. 2004). On a Bmp7-null background, BMP4 reduction causes a shortened 
OFT with hypoplastic OFT cushions, revealing dose-dependence and functional redundancy 
of BMP signaling in the OFT morphogenesis (Liu et al. 2004). 
Despite being expressed during early heart development, single gene deletions of Bmp5, 
Bmp6, or Bmp7 do not cause heart defects, likely due to redundancy of the BMP signaling 
family members (Kingsley et al. 1992; Jena et al. 1997; Dudley and Robertson 1997; Luo et al. 
1995; Solloway et al. 1998; Kim, Robertson, and Solloway 2001). BMP5 is expressed 
throughout the heart tube myocardium and later becomes restricted to the myocardium of 
the AVC and OFT in mouse and chicken embryos (Yamagishi et al. 2001; Solloway and 
Robertson 1999; Somi et al. 2004).  In mice, BMP6 is expressed in OFT endocardium and 
myocardium, and within the OFT and AVC mesenchyme (Kim, Robertson, and Solloway 
2001; Jones, Lyons, and Hogan 1991; Solloway and Robertson 1999; Yamagishi et al. 2001). 
BMP6 is not expressed in the developing chicken heart (Somi et al. 2004). BMP7 is robustly 
expressed throughout the myocardium of the developing hearts of mice and chickens 
(Solloway and Robertson 1999; Lyons, Hogan, and Robertson 1995; Somi et al. 2004). 
Combinations of gene deletions in mouse models reveal their essential roles in chamber 
formation and septal-valvulogenesis. Bmp5 and Bmp7 double deletion causes embryonic 
lethality at E10.5, with delayed heart development, no endocardial cushion formation or 
chamber septation, and abnormal pericardium (Solloway and Robertson 1999). Removal of 
Bmp6 and Bmp7 results in defects in OFT cushion development, chamber septation, and 
myocardial wall formation (Kim, Robertson, and Solloway 2001). Deletion of Bmp5 and 
Bmp6 does not cause heart defects (Solloway et al. 1998).   
Deletion of Alk3 from the myocardium or the endocardium disrupts endocardial cushion 
formation (Gaussin et al. 2002; Song, Fässler, et al. 2007; Ma et al. 2005). Myocardial deletion 
of Alk3 causes VSD and hypoplastic AVC cushions, with decreased TGF┚ signaling in the 
AVC myocardium (Gaussin et al. 2002). Deleting Alk3 specifically from the AVC 
myocardium disrupts AV valve maturation (Gaussin et al. 2005). Endocardial deletion of 
Alk3 causes hypoplastic cushions with reduced cushion mesenchyme to about 20% of 
normal (Ma et al. 2005; Song, Fässler, et al. 2007; Park et al. 2006; Rivera-Feliciano and Tabin 
2006). Endocardial deletion of Alk2 causes failure of EMT in AVC cushions along with 
decreased expression of EMT proteins MSX1 and SMAD2, an intracellular modulator of 
TGF┚ signaling (Wang, Sridurongrit, et al. 2005). The role of ALK2 in cushion formation 
appears to be specific to the endocardium, as conditional deletion of Alk2 from the 
myocardium has no effect on cushion development (Wang, Sridurongrit, et al. 2005). Ectopic 
expression of active ALK2 in the chicken ventricle endocardium induces EMT (Desgrosellier 
et al. 2005). CNCC-depletion of Alk3 or Alk2 disrupts CNCC invasion, resulting in a 
shortened OFT with defective proximal septation (Stottmann et al. 2004; Kaartinen et al. 
2004). Hypomorphic Bmpr2 alleles cause defects in proximal OFT septation and loss of 
semilunar valve formation, while AVC cushions form normally (Délot et al. 2003). However, 
completely abrogating Bmpr2 in mouse hearts causes an array of CHDs, such as DORV, 
VSD, and AVC cushion defects (Beppu et al. 2009). Disruption of Acvr2b causes postnatal 
death with abnormal cardiac septation (Oh and Li 1997). Deletion of Smad4 from the 
myocardium affects OFT positioning, with a DORV phenotype in one mouse model (Azhar 
et al. 2010). Conditional deletion of Smad4 in CNCC reduced the contribution of CNCC to 
OFT, causing defects in OFT cushion formation, septation, elongation, and positioning (Jia et 
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al. 2007; Ko et al. 2007; Nie et al. 2008). Deletion of Smad8 does not affect viability or heart 
development, but mice display defects in pulmonary vascular remodeling (Huang et al. 
2009).  
BMP signaling regulates SHF myocardialization and OFT morphogenesis in part by 
promoting miR-17-92 cluster transcription (Wang et al. 2010).  The miR-17-92 cluster has 
roles in lung and heart development (Lu et al. 2007; Ventura et al. 2008). It is expressed as a 
primary transcript that encodes six miRNAs (miR-17, -18a, -19a, -20a, -19b-1, and -92a-1). 
BMP regulates the transcription of miR-17-92 through SMAD binding sites in the 5’ region 
(Wang et al. 2010). In turn, miR-17-92 negatively regulates Isl1 and Tbx1 mRNA stability and 
translation (Wang et al. 2010). Deleting BMP reduces miR-17-92, causes misexpression of Isl1 
and Tbx1, and leads to defects in proximal OFT septation (Wang et al. 2010).  
Inhibition of BMP signaling is also critical for normal valvulo-septal formation. For example, 
Nkx2.5 is required for OFT development, in part by repressing BMP signaling (Prall et al. 
2007). Deleting Nkx2.5 results in expansion of SHF specification due to increased BMP 
expression, decreased proliferation, and failed OFT truncation. Disrupting the misregulated 
BMP signaling in the Nkx2.5 mutants by deleting Smad1 effectively rescues the proliferation 
and the OFT defects. Mutations in the BMP-inhibitor Smad6 cause hyperplasia of cardiac 
valves and OFT septation defects, due to unregulated BMP signaling (Galvin et al. 2000). 
Noggin blocks EMT in mouse explants and overexpression of noggin in chicken embryos 
causes OFT septation defects (Sugi et al. 2004; Allen et al. 2001). Mutations in chordin cause 
abnormal OFT septation, resembling syndromes associated with loss of CNCC (Bachiller et 
al. 2003).  
4. BMP induction of stem cells and progenitor cells to a cardiac fate 
Controlled differentiation of stem cells has relevance in translational research for pre-clinical 
cell grafting and for establishing cardiomyocyte cultures for drug discovery and toxicology. 
As primary inducers of cardiac differentiation, BMP cytokines have important roles in 
growth factor-based stem cell therapies for cardiac tissue repair. Use of growth factor 
peptides to induce cardiac muscle formation from embryonic stem (ES) cells has been 
researched for over a decade. BMP ligands have been proven to be important inductors of 
cardiac fate in multiple ES cell types. In mouse ES cells (mESC), BMP2 or BMP4 can activate 
cardiac differentiation, in combination with other factors such as Activin A or fibroblast 
growth factor 2 (FGF2) (Johansson and Wiles 1995; Kawai et al. 2004; Behfar et al. 2002). In 
the pluripotent mouse embryonal carcinoma cell line, P19C16, treatment with BMP4 
promotes cardiomyocyte formation and expression of ┙-MHC (Monzen et al. 1999; Monzen 
et al. 2001). Addition of noggin, a BMP inhibitor, prevents differentiation and this can be 
abolished by overexpressing BMP2, or SMAD1 and SMAD4 (Monzen et al. 1999; Monzen et 
al. 2001). In human ES cells (hESC), BMP4 promotes a cardiac fate (Takei et al. 2009; 
Kattman et al. 2011). BMP stimulation induces Sox17 expression,  which is important for 
directing mesoderm toward a cardiac fate (Stefanovic et al. 2009). Addition of BMP2 or 
BMP4 in hESC, along with Activin A and other factors, can reliably induce multipotent 
cardiovascular progenitors that can generate multiple cell lineages such as cardiomyocytes, 
smooth muscle cells, and endothelial cells in vitro and in vivo (Laflamme et al. 2007; 
Tomescot et al. 2007; Yang et al. 2008; Liu et al. 2007). Human induced pluripotent stem cells 
(iPSC) can also be induced to undergo cardiomyogenesis using similar multistep additions 
of factors, including BMP4 (Takahashi et al. 2007; Carvajal-Vergara et al. 2010; Kattman et al. 
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2011). BMP2 stimulation with FGF inhibition also induces multipotent cardiovascular 
progenitor cells in hESC, human iPSC, and primate ESC (Blin et al. 2010). BMP4 enhances 
simian ESC differentiation into cardiomyocytes as well (Hosseinkhani et al. 2007). Future 
studies of stem cells and progenitor cells may help develop peptide therapies to stimulate 
the proliferation and differentiation of self-renewing stem cells within the postnatal heart.  
5. Conclusion 
CHDs occur in nearly 1% of newborns and in over 5% of fetuses that do not survive to term 
in the Western world (Hoffman 1995; Hoffman and Kaplan 2002). Due to advances in 
medicine, there is a growing number of children and adults living with CHDs who require 
lifelong healthcare (Hoffman and Kaplan 2002). Therefore, understanding the molecular 
mechanisms of heart development and the underlying causes of CHDs has immediate 
translational significance. BMP signaling pathways are critical regulators of heart 
development in species as varied as fruit flies, chickens, mice, and humans. Mutations in the 
BMP pathway have been identified in humans with CHDs. This review discussed the critical 
roles of BMP signaling pathways in cardiac specification from the mesoderm, myocardial 
wall formation, valve development, chamber septation, and outflow tract morphogenesis. 
Because cardiac morphogenesis and BMP signaling pathways are evolutionarily conserved, 
information gleaned from a variety of model systems provides valuable insight into human 
heart development and CHDs. In the future this insight may help develop diagnostic tests 
and therapeutic options for people with CHDs. 
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